Is Patients With Pulmonary Disease Benefit a Program With Yogic Exercises?

January 27, 2016 updated by: Per Wandell, Karolinska Institutet

Subjective and Objective Effects After Yogic Exercises

Is Yogic Exercises (12 weeks) increasing respiratory function, functional capacity and quality of life in patients with obstructive lung diseases. With follow up after 6 months.

Study Overview

Status

Completed

Conditions

Detailed Description

Is Yogic Exercises increasing respiratory function in patients with obstructive lung diseases. Will YE improve respiratory muscle strength, functional capacity, inspiratory and expiratory pressure, lung function, perceived dyspnea, dyspnea-related distress (DD), less frequency of dyspnea and heart rate variability in patients with pulmonary disease. Qualitative content analysis will be performed on approximately 15 interviews with patients participated in the yoga group about their experiences and their benefits perceived/experienced of the yogic exercises

We want to try YE as an alternative treatment in patients with mild to severe pulmonary disease.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Huddinge
      • Stockholm, Huddinge, Sweden
        • Karolinska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mild to severe pulmonary obstructions according to GOLD 1-3 (Global Initiative for Chronic Obstructive Lung Disease),
  • FEV (forced expiratory volume) in one second (FEV1) % of predicted respiratory function (30% ≤ FEV1 ≤ 90%)
  • FEV1/FVC < 0.70 (<65 over 65 yrs). *FVC=forced vital capacity

Exclusion Criteria:

  • Severe neurological, orthopedic or rheumatologic injuries
  • Severely decreased thorax mobility and lung function.
  • Severe lung diseases
  • Other chronic diseases that will interfere with performance.
  • Under 200 meters on the 6MWT
  • Acute dyspnea
  • Surgery within 6 months
  • Medication affecting attention, sudden change of medication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Yogic exercises
Yogic exercises for lung disorders
Yogic exercises (YE) - 2 hours per week, 1h in each session
Active Comparator: physiotherapy
Physiotherapy during the yogic exercises
Physiotherapy (low intensity cardiovascular training and strength training) - 2 hours per week, 1 h in each session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dyspnea related distress (DD)
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Functional capacity
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
6 minutes Walking test
Patients will be followed 10-12 weeks, with follow-up after 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spirometry, Vital capacity
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Oxygen saturation (periphery)
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Respiration rate
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured manually
Patients will be followed 10-12 weeks, with follow-up after 6 months
CRQ, Chronic respiratory disease questionnaire
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
VAS- scale - perceived health
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Scoring between 0 (worst possible) and 10 (best possible)
Patients will be followed 10-12 weeks, with follow-up after 6 months
Maximal inspiratory and maximal expiratory pressure
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Perceived stress
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Will be measured using PSS-14 scale
Patients will be followed 10-12 weeks, with follow-up after 6 months
Sleep quality
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured with Pittsburgh sleep questionnaire index scale
Patients will be followed 10-12 weeks, with follow-up after 6 months
Anxiety and depression
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured with HADS-scale
Patients will be followed 10-12 weeks, with follow-up after 6 months
Self rated health
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Subjective complaints (perceived symptoms)
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Blood pressure
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Weight and height
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Health behaviour
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Measured with public health questionnaire (Folkhälsoenkäten in Swedish)
Patients will be followed 10-12 weeks, with follow-up after 6 months
Exercise diary
Time Frame: Patients will be followed 10-12 weeks, with follow-up after 6 months
Patients will be followed 10-12 weeks, with follow-up after 6 months
Spirometry, forced vital capacity (FVC)
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, Forced expiratory volume
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, Forced expiratory volume in one second (FEV1)
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, Ratio between forced expiratory volume in 1 second and forced vital capacity
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Spirometry, peak expiratory flow (PEF)
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Insomnia
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Measured with insomnia index scale
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Heart rate variability
Time Frame: Patients will be followed for 10-12 weeks, with follow-up after 6 months
Measured with Polar heart rate monitor
Patients will be followed for 10-12 weeks, with follow-up after 6 months
Qualitative content analysis
Time Frame: After Yoga intervention - one interview, with follow-up after 6 months
Inteviews with participants in yoga Group, and at follow-up also physiotherapy group
After Yoga intervention - one interview, with follow-up after 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Per Wändell, MD, PhD, Karolinska Institutet, Stockholm

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

August 25, 2014

First Submitted That Met QC Criteria

September 5, 2014

First Posted (Estimate)

September 8, 2014

Study Record Updates

Last Update Posted (Estimate)

January 28, 2016

Last Update Submitted That Met QC Criteria

January 27, 2016

Last Verified

September 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • DNR2011/248-31/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Yogic exercises

3
Subscribe